The company said its Q2 2024 revenue was $488.5 million, up 23.2% from $396.5 million a year earlier (23.4% in constant currency). Total Omnipod revenue reached $480.4 million, up 26.3%.

1. 01

   The company said its Q2 2024 revenue was $488.5 million, up 23.2% from $396.5 million a year earlier (23.4% in constant currency). Total Omnipod revenue reached $480.4 million, up 26.3%.

2. 02

   Insulet said gross margin for Q2 was 67.7%, up 90 basis points from 66.8% a year earlier. The figure includes a $13.5 million charge for inventory components it does not expect to use, which it said reduced gross margin by 280 basis points.

3. 03

   The company said net income for Q2 was $188.6 million ($2.59 per diluted share). Adjusted net income was $38.3 million ($0.55 per share), excluding a $151.7 million gain from releasing most of the company's valuation allowance and a $1.4 million investment loss.

4. 04

   The company raised its 2024 full-year revenue growth outlook to 16% to 19% in constant currency (from 14% to 18%) and its operating margin outlook to approximately 14.0% (from approximately 13.5%). It said it now expects gross margin to be closer to the high end of the 68% to 69% range.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.